Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barney Graham

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Microorganisms|January 28, 2026
Selective Budding of SARS-CoV-Like Particles from Glycolipid-Enriched Membrane Lipid Rafts and Host Gene ModulationManoj K Pastey, Yue Huang, Barney Graham
Frontiers in Cellular and Infection Microbiology|June 11, 2025
Decoding respiratory syncytial virus morphology: distinct structural and molecular signatures of spherical and filamentous particlesManoj K Pastey, Lewis H McCurdy, Barney Graham
Immunity|June 14, 2024
Longitudinal humoral analysis in RSV-infected infants identifies pre-existing RSV strain-specific G and evolving cross-reactive F antibodiesNadège Nziza, Wonyeong Jung, Maanasa Mendu, et al.
Vaccine|February 4, 2018
Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristicsJohan Vekemans, Vasee Moorthy, Brigitta Giersing, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 30, 2004
Prevalence of HCV coinfection in HIV-infected individuals in Nigeria and characterization of HCV genotypesSimon M Agwale, Lorine Tanimoto, Chad Womack, et al.
Plos One|October 27, 2018
Vaccination by microneedle patch with inactivated respiratory syncytial virus and monophosphoryl lipid A enhances the protective efficacy and diminishes inflammatory disease after challengeSoojin Park, Youri Lee, Young-Man Kwon, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2020
Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal BetacoronavirusesJennifer Hicks, Carleen Klumpp-Thomas, Heather Kalish, et al.
Journal of Virology|December 6, 2019
Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus InfectionVineet D Menachery, Kenneth H Dinnon, Boyd L Yount, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 2, 2002
Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022AKalpana Gupta, Michael Hudgens, Lawrence Corey, et al.
Research Square|November 16, 2022
Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive protection across divergent subgroupsGeoffrey Hutchinson, Olubukola Abiona, Cynthia Ziwawo, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Microorganisms|January 28, 2026
Selective Budding of SARS-CoV-Like Particles from Glycolipid-Enriched Membrane Lipid Rafts and Host Gene ModulationManoj K Pastey, Yue Huang, Barney Graham
Frontiers in Cellular and Infection Microbiology|June 11, 2025
Decoding respiratory syncytial virus morphology: distinct structural and molecular signatures of spherical and filamentous particlesManoj K Pastey, Lewis H McCurdy, Barney Graham
Immunity|June 14, 2024
Longitudinal humoral analysis in RSV-infected infants identifies pre-existing RSV strain-specific G and evolving cross-reactive F antibodiesNadège Nziza, Wonyeong Jung, Maanasa Mendu, et al.
Vaccine|February 4, 2018
Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristicsJohan Vekemans, Vasee Moorthy, Brigitta Giersing, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 30, 2004
Prevalence of HCV coinfection in HIV-infected individuals in Nigeria and characterization of HCV genotypesSimon M Agwale, Lorine Tanimoto, Chad Womack, et al.
Plos One|October 27, 2018
Vaccination by microneedle patch with inactivated respiratory syncytial virus and monophosphoryl lipid A enhances the protective efficacy and diminishes inflammatory disease after challengeSoojin Park, Youri Lee, Young-Man Kwon, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2020
Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal BetacoronavirusesJennifer Hicks, Carleen Klumpp-Thomas, Heather Kalish, et al.
Journal of Virology|December 6, 2019
Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus InfectionVineet D Menachery, Kenneth H Dinnon, Boyd L Yount, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 2, 2002
Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022AKalpana Gupta, Michael Hudgens, Lawrence Corey, et al.
Research Square|November 16, 2022
Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive protection across divergent subgroupsGeoffrey Hutchinson, Olubukola Abiona, Cynthia Ziwawo, et al.
Pageof 2